{"id":"https://openalex.org/W2045549010","doi":"https://doi.org/10.1002/art.23428","title":"An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus","display_name":"An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus","publication_year":2008,"publication_date":"2008-04-25","ids":{"openalex":"https://openalex.org/W2045549010","doi":"https://doi.org/10.1002/art.23428","mag":"2045549010","pmid":"https://pubmed.ncbi.nlm.nih.gov/18438845"},"language":"en","primary_location":{"id":"doi:10.1002/art.23428","doi":"https://doi.org/10.1002/art.23428","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.23428","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis & Rheumatism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023431099","display_name":"Frances Rena Bahjat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances Rena Bahjat","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111494728","display_name":"Polly R. Pine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Polly R. Pine","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030472111","display_name":"Andrea J. Reitsma","orcid":"https://orcid.org/0009-0005-9840-5376","observed_orcids":["https://orcid.org/0009-0005-9840-5376"]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Reitsma","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036230541","display_name":"Gail Cassafer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail Cassafer","raw_affiliation_strings":["San Francisco VA Medical Center, San Francisco, California","University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Francisco VA Medical Center, San Francisco, California","institution_ids":["https://openalex.org/I1315708478"]},{"raw_affiliation_string":"University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031511139","display_name":"Muhammad Baluom","orcid":"https://orcid.org/0000-0002-0625-3039","observed_orcids":["https://orcid.org/0000-0002-0625-3039"]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Baluom","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041366213","display_name":"Sunny Grillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunny Grillo","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062625211","display_name":"Betty Y Chang","orcid":"https://orcid.org/0009-0000-6363-2484","observed_orcids":["https://orcid.org/0009-0000-6363-2484"]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty Chang","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101833130","display_name":"Fei Zhao","orcid":"https://orcid.org/0000-0002-0958-3981","observed_orcids":["https://orcid.org/0000-0002-0958-3981"]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fei Fei Zhao","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113600276","display_name":"Donald G. Payan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald G. Payan","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109073298","display_name":"Elliott B. Grossbard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159901","display_name":"Rigel (United States)","ror":"https://ror.org/05j0yvv31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159901"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elliott B. Grossbard","raw_affiliation_strings":["Rigel Pharmaceuticals, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rigel Pharmaceuticals, South San Francisco, California","institution_ids":["https://openalex.org/I4210159901"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080133980","display_name":"David Daikh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David I. Daikh","raw_affiliation_strings":["San Francisco VA Medical Center, San Francisco, California","University of California, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Francisco VA Medical Center, San Francisco, California","institution_ids":["https://openalex.org/I1315708478"]},{"raw_affiliation_string":"University of California, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.5053,"has_fulltext":false,"cited_by_count":171,"citation_normalized_percentile":{"value":0.9893683,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"58","issue":"5","first_page":"1433","last_page":"1444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spleen-tyrosine-kinase-inhibitor","display_name":"spleen tyrosine kinase inhibitor","score":0.8690000176429749},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9589999914169312},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/nzb-w-f1-mice","display_name":"NZB/W F1 mice","score":0.7630000114440918},{"id":"https://openalex.org/keywords/fc-receptor-signaling","display_name":"Fc receptor signaling","score":0.8199999928474426},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.9909999966621399},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.7490000128746033},{"id":"https://openalex.org/keywords/kidney-disease","display_name":"kidney disease","score":0.7080000042915344},{"id":"https://openalex.org/keywords/arthus-reaction","display_name":"Arthus reaction","score":0.640999972820282},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.7749999761581421},{"id":"https://openalex.org/keywords/autoantibodies","display_name":"autoantibodies","score":0.7490000128746033},{"id":"https://openalex.org/keywords/oral-drug-therapy","display_name":"oral drug therapy","score":0.3919999897480011}],"concepts":[{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.6683862209320068},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.6157367825508118},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5434302687644958},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.537599503993988},{"id":"https://openalex.org/C35174551","wikidata":"https://www.wikidata.org/wiki/Q7660502","display_name":"Syk","level":4,"score":0.5084118247032166},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.456320583820343},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4439135193824768},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37971436977386475},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3792324662208557},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37674474716186523},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3055645823478699},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.29803666472435},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13265100121498108}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008814","descriptor_name":"Mice, Inbred NZB","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/art.23428","doi":"https://doi.org/10.1002/art.23428","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.23428","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis & Rheumatism","raw_type":"journal-article"},{"id":"pmid:18438845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18438845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis and rheumatism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1514879218","https://openalex.org/W1526518539","https://openalex.org/W1527959728","https://openalex.org/W1547552531","https://openalex.org/W1636612575","https://openalex.org/W1656464030","https://openalex.org/W1794852769","https://openalex.org/W1867547740","https://openalex.org/W1933354533","https://openalex.org/W1965830188","https://openalex.org/W1972108403","https://openalex.org/W1983513155","https://openalex.org/W1988153916","https://openalex.org/W1997702872","https://openalex.org/W2008924465","https://openalex.org/W2010569312","https://openalex.org/W2016127179","https://openalex.org/W2016899230","https://openalex.org/W2017335997","https://openalex.org/W2020220487","https://openalex.org/W2024081009","https://openalex.org/W2029993165","https://openalex.org/W2031097604","https://openalex.org/W2032575758","https://openalex.org/W2043263210","https://openalex.org/W2044732378","https://openalex.org/W2071157382","https://openalex.org/W2072970918","https://openalex.org/W2078158707","https://openalex.org/W2085406842","https://openalex.org/W2090045809","https://openalex.org/W2091989850","https://openalex.org/W2094295779","https://openalex.org/W2095726706","https://openalex.org/W2099704507","https://openalex.org/W2102602402","https://openalex.org/W2110956941","https://openalex.org/W2117631835","https://openalex.org/W2125673845","https://openalex.org/W2133363468","https://openalex.org/W2142022306","https://openalex.org/W2142417041","https://openalex.org/W2152621712","https://openalex.org/W2160910689","https://openalex.org/W2162283041","https://openalex.org/W2163889822","https://openalex.org/W2164596269","https://openalex.org/W2530180087","https://openalex.org/W2565516285","https://openalex.org/W2581095597","https://openalex.org/W2585147566"],"related_works":["https://openalex.org/W1530812788","https://openalex.org/W2600154033","https://openalex.org/W4308555274","https://openalex.org/W3144600210","https://openalex.org/W4407635691","https://openalex.org/W2129462286","https://openalex.org/W2896299871","https://openalex.org/W2760270300","https://openalex.org/W2123180657","https://openalex.org/W1813485308"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"whether":[3],"R788,":[4],"an":[5],"orally":[6],"bioavailable":[7],"small":[8],"molecule":[9],"inhibitor":[10,228],"of":[11,29,79,93,126,140,157,165,181,232,249],"spleen":[12,194],"tyrosine":[13],"kinase":[14],"(Syk)-dependent":[15],"signaling,":[16],"could":[17],"modulate":[18],"disease":[19,48,120,234],"in":[20,98,154,171,204,208,215,252],"lupus-prone":[21,141],"(NZB":[22],"x":[23],"NZW)F1":[24],"(NZB/NZW)":[25],"mice":[26,44,100,216],"via":[27],"inhibition":[28],"Fc":[30],"receptor":[31,36],"(FcR)":[32],"and":[33,46,55,61,64,77,84,128,133,136,188,235,255],"B":[34,85],"cell":[35,83,86],"signaling.":[37],"METHODS:":[38],"R788":[39,103,113,201],"was":[40,114],"administered":[41,115],"to":[42,117,212],"NZB/NZW":[43,99,142,209],"before":[45],"after":[47,119],"onset.":[49],"Proteinuria,":[50],"blood":[51],"urea":[52],"nitrogen":[53],"levels,":[54],"autoantibody":[56,144],"titers":[57,145],"were":[58,68,88,108,146,169,195],"examined":[59],"periodically,":[60],"overall":[62],"survival":[63,139],"renal":[65,131,233],"pathologic":[66],"features":[67],"assessed":[69],"following":[70,197],"long-term":[71,198],"treatment":[72],"(24-34":[73],"weeks).":[74],"The":[75],"distribution":[76],"immunophenotype":[78],"various":[80],"splenic":[81],"T":[82,160,183,191],"subpopulations":[87],"evaluated":[89],"at":[90],"the":[91,124,150,155,179,230],"time":[92],"study":[94],"termination.":[95],"Arthus":[96,206],"responses":[97,207],"pretreated":[101,217],"with":[102,218],"or":[104,118,167],"Fc-blocking":[105],"antibody":[106],"(anti-CD16/32)":[107],"also":[109],"examined.":[110],"RESULTS:":[111],"When":[112],"prior":[116],"onset,":[121],"it":[122],"delayed":[123],"onset":[125],"proteinuria":[127],"azotemia,":[129],"reduced":[130,205],"pathology":[132],"kidney":[134],"infiltrates,":[135],"significantly":[137],"prolonged":[138],"mice;":[143],"minimally":[147],"affected":[148],"throughout":[149],"study.":[151],"Dose-dependent":[152],"reductions":[153],"numbers":[156,180],"CD4+":[158],"activated":[159],"cells":[161,184,192],"expressing":[162,185],"high":[163],"levels":[164],"CD44":[166],"CD69":[168],"apparent":[170],"spleens":[172],"from":[173],"R788-treated":[174],"mice.":[175],"Minimal":[176],"effects":[177],"on":[178],"naive":[182],"CD62":[186],"ligand":[187],"total":[189],"CD8+":[190],"per":[193],"observed":[196],"drug":[199],"treatment.":[200],"pretreatment":[202],"resulted":[203],"mice,":[210],"similar":[211],"results":[213],"obtained":[214],"FcR-blocking":[219],"antibody.":[220],"CONCLUSION:":[221],"We":[222],"demonstrate":[223],"that":[224,244],"a":[225],"novel":[226],"Syk-selective":[227],"prevents":[229],"development":[231],"treats":[236],"established":[237],"murine":[238],"lupus":[239,254],"nephritis.":[240],"These":[241],"data":[242],"suggest":[243],"Syk":[245],"inhibitors":[246],"may":[247],"be":[248],"therapeutic":[250],"benefit":[251],"human":[253],"related":[256],"disorders.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":24}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}